Cargando…

Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study

BACKGROUND: Extracapsular extension (ECE) of prostate cancer (PCa) is closely related to the treatment and prognosis of patients, and radiomics has been widely used in the study of PCa. This study aimed to evaluate the value of a combined model considering magnetic resonance imaging (MRI)-based radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Liqin, Jin, Pengfei, Qian, Jing, Qiao, Xiaomeng, Bao, Jie, Wang, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425641/
https://www.ncbi.nlm.nih.gov/pubmed/37588741
http://dx.doi.org/10.21037/tcr-22-2750
_version_ 1785089880925143040
author Yang, Liqin
Jin, Pengfei
Qian, Jing
Qiao, Xiaomeng
Bao, Jie
Wang, Ximing
author_facet Yang, Liqin
Jin, Pengfei
Qian, Jing
Qiao, Xiaomeng
Bao, Jie
Wang, Ximing
author_sort Yang, Liqin
collection PubMed
description BACKGROUND: Extracapsular extension (ECE) of prostate cancer (PCa) is closely related to the treatment and prognosis of patients, and radiomics has been widely used in the study of PCa. This study aimed to evaluate the value of a combined model considering magnetic resonance imaging (MRI)-based radiomics and clinical parameters for predicting ECE in PCa. METHODS: A total of 392 PCa patients enrolled in this retrospective study were randomly divided into the training and validation sets at a ratio of 7:3. Radiologists assessed all lesions by Mehralivand grade. Radiomics features were extracted and selected to build a radiomics model, while clinical parameters were noted to construct the clinical model. The combined model was constructed by the integration of the radiomics model and clinical model. Meanwhile, the nomogram for predicting ECE was constructed based on the combined model. Then, the area under the receiver operating characteristic (ROC) curve (AUC), Delong test and the decision curve analysis (DCA) were used to compare the performance among the combined model, radiomics model, clinical model and Mehralivand grade. RESULTS: The AUC of the combined model in the validation set was comparable to that of the radiomics model [AUC =0.894 (95% confidence interval (CI): 0.837–0.950) vs. 0.835 (95% CI: 0.763–0.908), P>0.05]. In addition, the sensitivity of the combined model and radiomics model was 90.7% and 77.8%, with an accuracy of 81.4% and 76.3%, respectively. On the other hand, the AUCs of the Mehralivand grade of radiologists and clinical model were 0.774 (95% CI: 0.691–0.857) and 0.749 (95% CI: 0.658–0.840), respectively, in the validation set, which were lower than those in the combined model (P<0.05). The DCA implied that the combined model could obtain the maximum net clinical benefits compared with the clinical model, the Mehralivand grade and radiomics model. CONCLUSIONS: The combined model has a satisfactory predictive value for ECE in PCa patients compared with the clinical model, Mehralivand grade of radiologists, and the radiomics model.
format Online
Article
Text
id pubmed-10425641
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104256412023-08-16 Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study Yang, Liqin Jin, Pengfei Qian, Jing Qiao, Xiaomeng Bao, Jie Wang, Ximing Transl Cancer Res Original Article BACKGROUND: Extracapsular extension (ECE) of prostate cancer (PCa) is closely related to the treatment and prognosis of patients, and radiomics has been widely used in the study of PCa. This study aimed to evaluate the value of a combined model considering magnetic resonance imaging (MRI)-based radiomics and clinical parameters for predicting ECE in PCa. METHODS: A total of 392 PCa patients enrolled in this retrospective study were randomly divided into the training and validation sets at a ratio of 7:3. Radiologists assessed all lesions by Mehralivand grade. Radiomics features were extracted and selected to build a radiomics model, while clinical parameters were noted to construct the clinical model. The combined model was constructed by the integration of the radiomics model and clinical model. Meanwhile, the nomogram for predicting ECE was constructed based on the combined model. Then, the area under the receiver operating characteristic (ROC) curve (AUC), Delong test and the decision curve analysis (DCA) were used to compare the performance among the combined model, radiomics model, clinical model and Mehralivand grade. RESULTS: The AUC of the combined model in the validation set was comparable to that of the radiomics model [AUC =0.894 (95% confidence interval (CI): 0.837–0.950) vs. 0.835 (95% CI: 0.763–0.908), P>0.05]. In addition, the sensitivity of the combined model and radiomics model was 90.7% and 77.8%, with an accuracy of 81.4% and 76.3%, respectively. On the other hand, the AUCs of the Mehralivand grade of radiologists and clinical model were 0.774 (95% CI: 0.691–0.857) and 0.749 (95% CI: 0.658–0.840), respectively, in the validation set, which were lower than those in the combined model (P<0.05). The DCA implied that the combined model could obtain the maximum net clinical benefits compared with the clinical model, the Mehralivand grade and radiomics model. CONCLUSIONS: The combined model has a satisfactory predictive value for ECE in PCa patients compared with the clinical model, Mehralivand grade of radiologists, and the radiomics model. AME Publishing Company 2023-06-26 2023-07-31 /pmc/articles/PMC10425641/ /pubmed/37588741 http://dx.doi.org/10.21037/tcr-22-2750 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Yang, Liqin
Jin, Pengfei
Qian, Jing
Qiao, Xiaomeng
Bao, Jie
Wang, Ximing
Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study
title Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study
title_full Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study
title_fullStr Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study
title_full_unstemmed Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study
title_short Value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study
title_sort value of a combined magnetic resonance imaging-based radiomics-clinical model for predicting extracapsular extension in prostate cancer: a preliminary study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425641/
https://www.ncbi.nlm.nih.gov/pubmed/37588741
http://dx.doi.org/10.21037/tcr-22-2750
work_keys_str_mv AT yangliqin valueofacombinedmagneticresonanceimagingbasedradiomicsclinicalmodelforpredictingextracapsularextensioninprostatecancerapreliminarystudy
AT jinpengfei valueofacombinedmagneticresonanceimagingbasedradiomicsclinicalmodelforpredictingextracapsularextensioninprostatecancerapreliminarystudy
AT qianjing valueofacombinedmagneticresonanceimagingbasedradiomicsclinicalmodelforpredictingextracapsularextensioninprostatecancerapreliminarystudy
AT qiaoxiaomeng valueofacombinedmagneticresonanceimagingbasedradiomicsclinicalmodelforpredictingextracapsularextensioninprostatecancerapreliminarystudy
AT baojie valueofacombinedmagneticresonanceimagingbasedradiomicsclinicalmodelforpredictingextracapsularextensioninprostatecancerapreliminarystudy
AT wangximing valueofacombinedmagneticresonanceimagingbasedradiomicsclinicalmodelforpredictingextracapsularextensioninprostatecancerapreliminarystudy